The Trophin lab focuses on the role of neurotrophic factors, particularly Brain-Derived Neurotrophic Factor (BDNF) and its receptor TRKB, in plasticity of the adult brain and in the mechanisms of ...
Hosted on MSN3mon
Oxford discovery could pave way for Huntington's disease treatmentknown as indirect pathway spiny projection neurons (iSPNs), might cause a dopamine imbalance when missing a vital signal from the neurotrophin receptor TrkB. This imbalance is linked to early ...
2013;8(2):175-192. BDNF and NGF are neurotrophins that promote neuronal survival and plasticity through binding to their specific high-affinity tyrosine kinase receptors (TrkB and TrkA ...
NGF binds to TrkA; BDNF and neurotrophin 4 bind to TrkB; neurotrophin 3 binds to TrkC. BDNF, NGF, and all the receptors are known as targets for therapy in AD. Also, for PD, BDNF is a therapeutic ...
As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...
The Trophin lab focuses on the role of Brain-Derived Neurotrophic Factor (BDNF) and its receptor TRKB in the plasticity and in the mechanisms of drugs used for the treatment of brain disorders. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback